Information Provided By: 
Fly News Breaks for February 28, 2020
AZN
Feb 28, 2020 | 08:14 EDT
Cowen analyst Steve Scala called AstraZeneca a European Best Idea as its product momentum and high relative growth can allow it to outperform on an extended basis if management can continue to execute. Its low U.S. exposure makes the company less vulnerable to election rhetoric. Scala reiterated his Outperform rating and $55 price target on AstraZeneca shares.
News For AZN From the Last 2 Days
AZN
Apr 23, 2024 | 11:16 EDT
Bearish flow noted in AstraZeneca with 3,362 puts trading, or 1.7x expected. Most active are 4/26 weekly 70 puts and May-24 70 calls, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 1.72, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 25th.
